NCT06207812 Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis
| NCT ID | NCT06207812 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Lymphomatoid Papulosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-01-19 |
| Primary Completion | 2028-01-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-01-19 with a primary completion date of 2028-01-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To follow up with all our participants with juvenile-onset mycosis fungoides, check on their status, and ask them or their parents about long term outcomes associated with their condition.
Eligibility Criteria
Inclusion Criteria: -To be eligible, participants had to be diagnosed with jMF or lyp before age 20. In the case of participants below the age of 18, parents and not the children will be contacted for participation (children are exempt from participation as their parents may answer our study questions). Exclusion Criteria: -Participants older than 20 years of age at diagnosis
Contact & Investigator
Julia Dai, MD
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT06207812 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lymphomatoid Papulosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06207812 currently recruiting?
Yes, NCT06207812 is actively recruiting participants. Contact the research team at jdai6@mdanderson.org for enrollment information.
Where is the NCT06207812 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT06207812 clinical trial?
NCT06207812 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Julia Dai, MD at M.D. Anderson Cancer Center. The trial plans to enroll 100 participants.